NCT00359814View on ClinicalTrials.gov

Exchange of Azathioprine by Mycophenolatmofetile and Cyclosporine A Dose Reduction After Heart Transplantation

NACompletedINTERVENTIONAL
Enrollment

23

Participants

Timeline

Start Date

November 30, 2004

Primary Completion Date

June 30, 2008

Study Completion Date

June 30, 2008

Conditions
Heart Transplantation
Interventions
DRUG

Mycophenolatmofetile

Mycophenolatmofetile administration: was started with 250 mg/daily at day 1, the start dose was increased about 250 mg/daily every week till 2 g/daily

DRUG

Cyclosporin A

Cyclosporin A reduction: Cyclosporin A trough level reduction started after week 8. The new target range was 50 to 90 ng/ml

Trial Locations (1)

30625

Hannover Medical School, Department of Thoracic and Cardiovascular Surgery, Hanover

All Listed Sponsors
collaborator

Hoffmann-La Roche

INDUSTRY

lead

Hannover Medical School

OTHER

NCT00359814 - Exchange of Azathioprine by Mycophenolatmofetile and Cyclosporine A Dose Reduction After Heart Transplantation | Biotech Hunter | Biotech Hunter